Literature DB >> 2669629

Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever.

F Gudiol1, R Pallares, J Carratala, F Bolao, J Ariza, G Rufi, P F Viladrich.   

Abstract

A study of 43 patients with Mediterranean spotted fever showed that a 2-day course of ciprofloxacin or a 2-day course of doxycycline may be an effective mode of therapy. All patients in both arms of the study were cured; however, doxycycline produced a more rapid defervescence.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2669629      PMCID： PMC284272          DOI： 10.1128/AAC.33.6.987

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay.

Authors:  D Raoult; P Roussellier; V Galicher; R Perez; J Tamalet
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

2.  Serological diagnosis of Mediterranean spotted fever.

Authors:  E Edlinger
Journal:  Ann Microbiol (Paris)       Date:  1979 Feb-Mar

3.  Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases.

Authors:  D Raoult; P J Weiller; A Chagnon; H Chaudet; H Gallais; P Casanova
Journal:  Am J Trop Med Hyg       Date:  1986-07       Impact factor: 2.345

4.  Comparative, randomized trial of one-day doxycycline versus 10-day tetracycline therapy for Mediterranean spotted fever.

Authors:  F Bella-Cueto; B Font-Creus; F Segura-Porta; E Espejo-Arenas; P López-Parés; T Muñoz-Espín
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

Review 5.  Mediterranean spotted fever: a cooperative study of 227 cases.

Authors:  B Font-Creus; F Bella-Cueto; E Espejo-Arenas; R Vidal-Sanahuja; T Muñoz-Espin; M Nolla-Salas; A Casagran-Borrell; J Mercade-Cuesta; F Segura-Porta
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

6.  Mediterranean spotted fever in Belgium.

Authors:  M Lambert; T Dugernier; G Bigaignon; J Rahier; P Piot
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

7.  Autochthonic Mediterranean spotted fever in West Germany.

Authors:  S Staszewski; E B Helm; W Stille
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

8.  Ciprofloxacin therapy for Mediterranean spotted fever.

Authors:  D Raoult; H Gallais; P De Micco; P Casanova
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

9.  [Malignant form of Mediterranean boutonneuse fever. 6 cases].

Authors:  D Raoult; H Gallais; A Ottomani; J P Resch; D Tichadou; P De Micco; P Casanova
Journal:  Presse Med       Date:  1983-10-29       Impact factor: 1.228

10.  Ciprofloxacin: in vitro, experimental, and clinical evaluation.

Authors:  H Thadepalli; M B Bansal; B Rao; R See; S K Chuah; R Marshall; V K Dhawan
Journal:  Rev Infect Dis       Date:  1988 May-Jun
View more
  15 in total

1.  Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever.

Authors:  R Ruiz Beltrán; J I Herrero Herrero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

Review 2.  Antimicrobial therapy of rickettsial diseases.

Authors:  D Raoult; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

Review 3.  Optimum treatment of intracellular infection.

Authors:  M Maurin; D Raoult
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

4.  Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever.

Authors:  F Bella; B Font; S Uriz; T Muñoz; E Espejo; J Traveria; J A Serrano; F Segura
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

5.  Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs.

Authors:  E B Breitschwerdt; M G Davidson; D P Aucoin; M G Levy; N S Szabados; B C Hegarty; A L Kuehne; R L James
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

6.  Randomized Trial of Clarithromycin for Mediterranean Spotted Fever.

Authors:  Esperança Anton; Tomas Muñoz; Francisco Javier Travería; Gemma Navarro; Bernat Font; Isabel Sanfeliu; Ferran Segura
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

Review 7.  Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention.

Authors:  Göran Günther; Mats Haglund
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Prospective Cohort Study of Single-Day Doxycycline Therapy for Mediterranean Spotted Fever.

Authors:  Elena Espejo; Marta Andrés; Maria-Consol Garcia; Anna Fajardo; Josefa Pérez; Feliu Bella
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 9.  Quinolones in intracellular infections.

Authors:  J C Pechère
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 10.  Antibiotic treatment of rickettsiosis, recent advances and current concepts.

Authors:  D Raoult
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.